Kochi, April 2026: Aster Medcity has introduced India’s first “smart” Adaptive Deep Brain Stimulation (aDBS) technology, marking a major breakthrough in the treatment of Parkinson’s Disease.
The advanced system, launched at the hospital’s Parkinson’s and Movement Disorders Centre, represents a significant upgrade over conventional Deep Brain Stimulation (DBS) therapies, which deliver continuous and fixed electrical stimulation to the brain.
Unlike traditional methods, the newly introduced adaptive DBS technology continuously monitors brain signals linked to Parkinson’s symptoms and automatically adjusts stimulation levels in real time. This enables a more personalised and responsive treatment approach tailored to each patient’s condition.
Medical experts highlight that this innovation could significantly improve symptom control, reduce side effects, and enhance overall quality of life for patients suffering from advanced stages of Parkinson’s disease. The technology works by responding dynamically to fluctuations in brain activity, a capability that conventional DBS systems lack.
Adaptive DBS is considered a next-generation advancement in neurological care, as it shifts treatment from a static to a real-time, feedback-driven model. The launch positions Aster Medcity among the leading healthcare institutions in India adopting cutting-edge neurotechnology for complex disorders.
This development is expected to open new possibilities in the management of movement disorders and reinforce India’s growing role in advanced medical innovation.